|Day's Range||33.95 - 34.26|
|52 Week Range||25.25 - 36.82|
|PE Ratio (TTM)||24.24|
|Dividend & Yield||1.03 (3.00%)|
|1y Target Est||N/A|
Roche Holding AG (RHHBY) announced new retrospective data analyses for idiopathic pulmonary fibrosis (IPF) drug, Esbriet.
In 1Q17, Amgen’s (AMGN) Nplate generated revenues of ~$154 million, which reflected a year-over-year growth rate of 9%.
We issued an updated research report on Alnylam Pharmaceuticals, Inc. (ALNY) on May 23, 2017.